Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Buy
10,261
+705
+7% +$152K 1.39% 15
2026
Q1
$2.08M Buy
9,556
+674
+8% +$150K 1.38% 18
2025
Q4
$2.03M Buy
8,882
+160
+2% +$36.4K 1.39% 20
2025
Q3
$2.02M Buy
8,722
+239
+3% +$48.7K 1.4% 17
2025
Q2
$1.57M Sell
8,483
-212
-2% -$39.4K 1.27% 18
2025
Q1
$1.82M Buy
8,695
+126
+1% +$24.5K 1.73% 12
2024
Q4
$1.52M Buy
+8,569
New +$1.58M 1.55% 15

Other funds holding ABBV

WinCap Financial's ABBV Position: Q2 2026 in Review

WinCap Financial increased its AbbVie (ABBV) stake by 7.4% in Q2 2026, buying an estimated $152K and bringing the position to 10,261 shares worth $2.58M. The position accounts for 1.39% of the portfolio, ranked #15.

WinCap Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WinCap Financial held 10,261 shares of AbbVie worth $2.58M as of Q2 2026.
  • WinCap Financial bought 705 AbbVie shares in Q2 2026, an estimated $152K.
  • AbbVie made up 1.39% of WinCap Financial's portfolio in Q2 2026, its #15 holding.
  • WinCap Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WinCap Financial's 13F filing for Q2 2026, filed 9 Jul 2026.